JP2001500506A - ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン - Google Patents

ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン

Info

Publication number
JP2001500506A
JP2001500506A JP10513761A JP51376198A JP2001500506A JP 2001500506 A JP2001500506 A JP 2001500506A JP 10513761 A JP10513761 A JP 10513761A JP 51376198 A JP51376198 A JP 51376198A JP 2001500506 A JP2001500506 A JP 2001500506A
Authority
JP
Japan
Prior art keywords
compound
alkyl
halo
aryl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10513761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001500506A5 (https=
Inventor
エフ． レーン，ダイナナス
ビー． クーパー，アラン
ケイ． マラムス，アラン
ジェイ． ドール，ロナルド
ノロージ，エフ．ジョージ
ジー． タベラス，アーサー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2001500506A publication Critical patent/JP2001500506A/ja
Publication of JP2001500506A5 publication Critical patent/JP2001500506A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
JP10513761A 1996-09-13 1997-09-11 ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン Ceased JP2001500506A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71370596A 1996-09-13 1996-09-13
US08/713,705 1996-09-13
PCT/US1997/015902 WO1998011097A1 (en) 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Publications (2)

Publication Number Publication Date
JP2001500506A true JP2001500506A (ja) 2001-01-16
JP2001500506A5 JP2001500506A5 (https=) 2005-05-12

Family

ID=24867191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10513761A Ceased JP2001500506A (ja) 1996-09-13 1997-09-11 ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン

Country Status (13)

Country Link
EP (1) EP0931077B1 (https=)
JP (1) JP2001500506A (https=)
KR (1) KR20000036102A (https=)
CN (1) CN1104428C (https=)
AT (1) ATE294172T1 (https=)
AU (1) AU4337597A (https=)
CA (1) CA2264666A1 (https=)
DE (1) DE69733142T2 (https=)
ES (1) ES2242232T3 (https=)
HU (1) HUP0000073A3 (https=)
IL (1) IL128926A0 (https=)
NZ (1) NZ334341A (https=)
WO (1) WO1998011097A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910144A (pt) 1998-01-21 2002-04-02 Millennium Pharm Inc Antagonistas de receptores de quimiocinas e seu uso
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2005017160A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
RU2408584C2 (ru) 2005-06-23 2011-01-10 Мерк Шарп Энд Домэ Корп. Ингибиторы тирозинкиназы
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
EP2081905B1 (en) 2006-07-28 2012-09-12 Boehringer Ingelheim International GmbH Sulfonyl compounds which modulate the cb2 receptor
JP5492092B2 (ja) 2007-11-07 2014-05-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節する化合物
EP2326629B1 (en) 2008-07-10 2013-10-02 Boehringer Ingelheim International GmbH Sulfone compounds which modulate the cb2 receptor
WO2010036630A2 (en) 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2010096371A2 (en) 2009-02-18 2010-08-26 Boehringer Ingelheim International Gmbh Heterocyclic compounds which modulate the cb2 receptor
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) * 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節するアゼチジン２−カルボキサミド誘導体
JP2013505295A (ja) 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を選択的に調節する化合物
US9315454B2 (en) 2010-01-15 2016-04-19 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
EP2542539B1 (en) 2010-03-05 2014-02-26 Boehringer Ingelheim International GmbH Tetrazole compounds which selectively modulate the cb2 receptor
JP5746764B2 (ja) 2010-07-22 2015-07-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節する化合物
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
SG48750A1 (en) * 1993-10-15 1998-05-18 Schering Corp Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
IL128926A0 (en) 2000-02-17
CN1236365A (zh) 1999-11-24
DE69733142D1 (de) 2005-06-02
EP0931077B1 (en) 2005-04-27
ATE294172T1 (de) 2005-05-15
CA2264666A1 (en) 1998-03-19
EP0931077A1 (en) 1999-07-28
NZ334341A (en) 2001-01-26
DE69733142T2 (de) 2006-03-16
HUP0000073A2 (hu) 2001-10-28
CN1104428C (zh) 2003-04-02
ES2242232T3 (es) 2005-11-01
WO1998011097A1 (en) 1998-03-19
KR20000036102A (ko) 2000-06-26
HUP0000073A3 (en) 2002-02-28
AU4337597A (en) 1998-04-02

Similar Documents

Publication Publication Date Title
JP2001500506A (ja) ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン
US6399615B1 (en) Farnesyl protein transferase inhibitors
JP2999556B2 (ja) ファルネシルタンパク質トランスフェラーゼの阻害に有用な三環式化合物
JP3095781B2 (ja) Ｇ−タンパク質機能の阻害および増殖性疾患の処置に有用な三環式アミドおよび尿素化合物
CN1251097B (zh) 具有血管生成抑制活性的酞嗪类化合物
TWI641602B (zh) 單環吡啶衍生物
CA2813607C (en) Substituted pyridazine carboxamide compounds
JP2002506444A (ja) ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビター
TW201105325A (en) 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides
JPWO1995034559A1 (ja) 新規化合物、その製法および抗腫瘍剤
JP4155827B2 (ja) オキサゾロ−およびフロピリミジンならびに腫瘍に対する医薬としてのその使用
US5958940A (en) Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
KR20210049096A (ko) 암을 치료하기에 유용한 ErbB 조절자로서의 4-치환된 피롤로[2,3-b]피리딘
KR100640672B1 (ko) 파르네실 단백질 트랜스퍼라제의 억제에 유용한 벤즈피리도 사이클로헵탄 화합물 및 이를 포함하는 약제학적 조성물
KR20220044753A (ko) 아세틸 조효소 a 신테타제 단쇄 2(acss2)의 소분자 억제제
JP2001500507A (ja) ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ピペリジニル化合物
JP3269636B2 (ja) ファルネシルタンパク質トランスフェラーゼインヒビターとして有用な三環式ケトアミド誘導体
JP2003514905A (ja) ピラジノン系トロンビン阻害薬
JP2001500505A (ja) Ｆｐｔインヒビターとして有用な三環式化合物
CN114867718B (zh) 新型吲唑衍生物及其用途
JP2000513034A (ja) ファルネシルタンパク質トランスフェラーゼインヒビターとして有用なベンゾ（５，６）シクロヘプタピリジン化合物
KR20010013826A (ko) 신규한 파네실-단백질 트랜스퍼라제의 트리사이클릭설폰아미드 억제제
JP2002542292A (ja) トロンビン阻害物質
JP3153555B2 (ja) ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ｎ―シアノイミン
ES2224413T3 (es) Derivados de benzo(5,6)ciclohepta(1,2-b)piridina utiles para inhibir farnesil proteina trasferasa.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080507

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080930

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081125